Left Calgary tonight after a wonderful CRA SCR #ASM25. A great platform to present original data an even better place to reconnect with colleagues and friends. The community continues to grow but still has a small town feel (in a good way!). See you in Halifax!

U of M Rady Faculty uManitoba Research UManitoba Science

Great to see this very important work in press. Predicting RA in at-risk individuals across the globe.

Check out this opportunity for mid-career scientists to join a unique and supportive group of Immunology-focussed researchers in Canada.

NEW! EULAR & ACR have developed risk stratification criteria for rheumatoid arthritis (RA). The criteria have been developed for people with arthralgia in secondary care who are considered at risk for RA. Learn more!

Research shows #calprotectin, a marker of #NeutrophilActivation, as a potential early indicator of #AtheroscleroticCardiovascularDisease. Elevated calprotectin levels were shown to predict future #HeartDisease risk, even in individuals without symptoms: cutt.ly/arx5jbId

In a large SLE cohort, serum S100A8/A9 levels were elevated in patients with cognitive impairment. Changes in S100A8/A9 levels also corresponded with changes in cognitive status over one year AC&R doi.org/10.1002/acr.25…

We're hiring! The Dept. of Internal Medicine University of Manitoba seeks an Asst. Prof. / Canada Research Chair Tier 2 in Structural/Spatial Proteomics 🏥 Based @ MCPSB HSC Winnipeg 🔬 MS, AI, disease mechanisms 📩 Apply: universityaffairs.ca/search-job/?jo… #CRC #Proteomics #teamMassSpec #asms2025

Looking forward to this event with an amazing lineup of speakers!🥳 I am co-chairing the symposium with Dr. Liam O'Neil😀 Thank you to the committee for helping organize & thank you to Research Manitoba for the grant to help fund the day🙏🏻🙏🏻 U of M Rady Faculty uManitoba Research

Way to go!

Phase 2 trial: Among individuals with anti-CCP levels ≥2x ULN, 12 months of hydroxychloroquine did not prevent the development of clinical rheumatoid arthritis at 36 months Arthritis & Rheumatology doi.org/10.1002/art.43…

📣NEW! CRA/CanRIO living guidelines Have you read the latest CRA/Canadian Rheumatology in Immuno-oncology (CanRIO) living guidelines for the management of baseline immunosuppression in individuals with pre-existing rheumatic diseases initiating immune checkpoint inhibitors? Learn more▶️youtube.com/watch?v=y6BQZW…

Thanks to everyone who attended the abstract session today - new insights into the etiology of RA #ACR25